233 related articles for article (PubMed ID: 25736784)
21. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of key microRNAs in pancreatic cancer development.
Baradaran B; Shahbazi R; Khordadmehr M
Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
[TBL] [Abstract][Full Text] [Related]
23. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
[TBL] [Abstract][Full Text] [Related]
24. Mantle cell lymphoma: transcriptional regulation by microRNAs.
Di Lisio L; Gómez-López G; Sánchez-Beato M; Gómez-Abad C; Rodríguez ME; Villuendas R; Ferreira BI; Carro A; Rico D; Mollejo M; Martínez MA; Menárguez J; Díaz-Alderete A; Gil J; Cigudosa JC; Pisano DG; Piris MA; Martínez N
Leukemia; 2010 Jul; 24(7):1335-42. PubMed ID: 20485376
[TBL] [Abstract][Full Text] [Related]
25. Macro-role of microRNA in gastric cancer.
Link A; Kupcinskas J; Wex T; Malfertheiner P
Dig Dis; 2012; 30(3):255-67. PubMed ID: 22722550
[TBL] [Abstract][Full Text] [Related]
26. Aberrant microRNA expression in tumor mycosis fungoides.
Papadavid E; Braoudaki M; Bourdakou M; Lykoudi A; Nikolaou V; Tounta G; Ekonomidi A; Athanasiadis E; Spyrou G; Antoniou C; Kitsiou-Tzeli S; Rigopoulos D; Kolialexi A
Tumour Biol; 2016 Nov; 37(11):14667-14675. PubMed ID: 27623940
[TBL] [Abstract][Full Text] [Related]
27. Functions and mechanisms of miR-186 in human cancer.
Wang Z; Sha HH; Li HJ
Biomed Pharmacother; 2019 Nov; 119():109428. PubMed ID: 31525641
[TBL] [Abstract][Full Text] [Related]
28. Role of microRNAs in primary central nervous system lymphomas.
Yu X; Li Z; Shen J; Chan MT; Wu WK
Cell Prolif; 2016 Apr; 49(2):147-53. PubMed ID: 26990358
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
30. Challenges and opportunities of microRNAs in lymphomas.
De Tullio G; De Fazio V; Sgherza N; Minoia C; Serratì S; Merchionne F; Loseto G; Iacobazzi A; Rana A; Petrillo P; Silvestris N; Iacopino P; Guarini A
Molecules; 2014 Sep; 19(9):14723-81. PubMed ID: 25232701
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of deregulated microRNAs in uveal melanomas.
Falzone L; Romano GL; Salemi R; Bucolo C; Tomasello B; Lupo G; Anfuso CD; Spandidos DA; Libra M; Candido S
Mol Med Rep; 2019 Apr; 19(4):2599-2610. PubMed ID: 30816460
[TBL] [Abstract][Full Text] [Related]
32. Aberrantly expressed microRNAs in the context of bladder tumorigenesis.
Lee JY; Ryu DS; Kim WJ; Kim SJ
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S52-9. PubMed ID: 27326408
[TBL] [Abstract][Full Text] [Related]
33. microRNAs: Key Players in Hematopoiesis.
Raghuwanshi S; Karnati HK; Sarvothaman S; Gutti U; Saladi RG; Tummala PR; Gutti RK
Adv Exp Med Biol; 2015; 887():171-211. PubMed ID: 26662992
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
van Schooneveld E; Wildiers H; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2015 Feb; 17():21. PubMed ID: 25849621
[TBL] [Abstract][Full Text] [Related]
35. Pivotal MicroRNAs in Melanoma: A Mini-Review.
Deng Z; Hao J; Lei D; He Y; Lu L; He L
Mol Diagn Ther; 2016 Oct; 20(5):449-55. PubMed ID: 27351922
[TBL] [Abstract][Full Text] [Related]
36. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
[TBL] [Abstract][Full Text] [Related]
37. microRNAs and cancer: role in tumorigenesis, patient classification and therapy.
Hernando E
Clin Transl Oncol; 2007 Mar; 9(3):155-60. PubMed ID: 17403626
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs and their role in environmental chemical carcinogenesis.
Li M; Huo X; Davuljigari CB; Dai Q; Xu X
Environ Geochem Health; 2019 Feb; 41(1):225-247. PubMed ID: 30171477
[TBL] [Abstract][Full Text] [Related]
39. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
40. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
